My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Octreoscan 111 MBq/mL, kit for radiopharmaceutical preparation



Curium Netherlands B.V.PA0690/001/001

Main Information

Trade NameOctreoscan 111 MBq/mL, kit for radiopharmaceutical preparation
Active SubstancesIndium (111 in) chloride solution
Pentetreotide
Dosage FormKit for radiopharmaceutical preparation
Licence HolderCurium Netherlands B.V.
Licence NumberPA0690/001/001

Group Information

ATC CodeV09AX01 indium (111In) pentetic acid

Status

License statusAuthorised
Licence Issued08/06/1995
Legal statusProduct subject to Restricted Prescription (C)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see: Summary of Product Characteristics, section 4.2).
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print